155 related articles for article (PubMed ID: 2499101)
1. The immunocytochemical demonstration of basement membrane deposition in transitional cell carcinoma of bladder.
Zuk RJ; Baithun SI; Martin JE; Cox EL; Revell PA
Virchows Arch A Pathol Anat Histopathol; 1989; 414(5):447-52. PubMed ID: 2499101
[TBL] [Abstract][Full Text] [Related]
2. Basement membranes in urothelial carcinoma.
Conn IG; Crocker J; Wallace DM; Hughes MA; Hilton CJ
Br J Urol; 1987 Dec; 60(6):536-42. PubMed ID: 3427340
[TBL] [Abstract][Full Text] [Related]
3. Laminin--a basement membrane specific glycoprotein--in bladder carcinomas.
Hashimoto H; Sakashita S
Urol Int; 1986; 41(4):248-53. PubMed ID: 3787845
[TBL] [Abstract][Full Text] [Related]
4. Collagen IV staining pattern in bladder carcinomas: relationship to prognosis.
Daher N; Abourachid H; Bove N; Petit J; Burtin P
Br J Cancer; 1987 Jun; 55(6):665-71. PubMed ID: 3304387
[TBL] [Abstract][Full Text] [Related]
5. Distribution of basement membranes in primary and metastatic carcinomas of the prostate.
Bonkhoff H; Wernert N; Dhom G; Remberger K
Hum Pathol; 1992 Aug; 23(8):934-9. PubMed ID: 1644438
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of basement membrane morphology, tumour histology and morphometry in superficial bladder cancer.
Lipponen PK
J Cancer Res Clin Oncol; 1993; 119(5):295-300. PubMed ID: 7680044
[TBL] [Abstract][Full Text] [Related]
7. Basement membrane and tumor invasion: ultrastructural observations in the basement membrane of rat bladder with invasive transitional cell carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Zhang XH; Takenaka I
Urol Res; 1994; 22(5):317-21. PubMed ID: 7879318
[TBL] [Abstract][Full Text] [Related]
8. [Cellular architecture of papillary and nonpapillary transitional cell carcinoma].
Moriyama M
Nihon Hinyokika Gakkai Zasshi; 1989 Jul; 80(7):1017-24. PubMed ID: 2607715
[TBL] [Abstract][Full Text] [Related]
9. [Ultrastructural observations on 10 cases of transitional cell carcinoma of the human bladder].
Liu J; Zhou KZ
Zhonghua Bing Li Xue Za Zhi; 1986 Sep; 15(3):220-2. PubMed ID: 2953464
[No Abstract] [Full Text] [Related]
10. p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression.
Soini Y; Turpeenniemi-Hujanen T; Kamel D; Autio-Harmainen H; Risteli J; Risteli L; Nuorva K; Pääkkö P; Vähäkangas K
Br J Cancer; 1993 Nov; 68(5):1029-35. PubMed ID: 8217593
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical demonstration of p21ras in normal and transitional cell carcinoma urothelium.
Dunn TL; Seymour GJ; Gardiner RA; Strutton GM; Lavin MF
J Pathol; 1988 Sep; 156(1):59-65. PubMed ID: 3057152
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of type IV collagen and laminin immunoreactivity in urothelial carcinomas of the bladder.
Schapers RF; Pauwels RP; Havenith MG; Smeets AW; van den Brandt PA; Bosman FT
Cancer; 1990 Dec; 66(12):2583-8. PubMed ID: 2249199
[TBL] [Abstract][Full Text] [Related]
13. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
Deen S; Ball RY
Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining with monoclonal antibody 32-2B to desmosomal glycoprotein 1. Its role in the histological assessment of urothelial carcinomas.
Conn IG; Vilela MJ; Garrod DR; Crocker J; Wallace DM
Br J Urol; 1990 Feb; 65(2):176-80. PubMed ID: 2317652
[TBL] [Abstract][Full Text] [Related]
15. Morphological changes in the basement membrane during progression from non-invasive to invasive rat bladder cancer induced by N-butyl-N-(4-hydoxybutyl) nitrosamine.
Zhang XH; Takenaka I
Br J Urol; 1997 Mar; 79(3):378-82. PubMed ID: 9117217
[TBL] [Abstract][Full Text] [Related]
16. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
17. Distribution of type IV collagen immunoreactivity to assess questionable early stromal invasion.
Stewart CJ; McNicol AM
J Clin Pathol; 1992 Jan; 45(1):9-15. PubMed ID: 1740529
[TBL] [Abstract][Full Text] [Related]
18. Invading squamous cell carcinoma can retain a basal lamina. An immunohistochemical study using a monoclonal antibody to type IV collagen.
Gusterson BA; Warburton MJ; Mitchell D; Kraft N; Hancock WW
Lab Invest; 1984 Jul; 51(1):82-7. PubMed ID: 6737996
[TBL] [Abstract][Full Text] [Related]
19. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
[TBL] [Abstract][Full Text] [Related]
20. Relation between basement membrane degradation and serum levels of laminin P1 in patients with transitional cell carcinoma of the bladder.
Abou Farha KM; Menheere PP; Nieman FH; Janknegt RA; Arends JW
Urol Int; 1993; 50(1):13-6. PubMed ID: 8434420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
